probenecid has been researched along with adenosine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Craig, CG; Temple, SD; White, TD | 1 |
| Knowles, KP; Knowles, R; Li, Y; Rosenberg, PA | 1 |
| Dubey, RK; Gillespie, DG; Jackson, EK; Mi, Z | 1 |
| Florio, C; Frausin, F; Gaion, RM; Vertua, R | 1 |
| Gean, PW; Lu, KT | 1 |
| Christie, MJ; Hack, SP; Vaughan, CW | 1 |
| DAVOREN, PR; SUTHERLAND, EW | 1 |
| Dubey, RK; Jackson, EK; Mi, Z; Tofovic, SP; Zacharia, LC | 1 |
| Bianciotti, LG; Burdet, J; Davio, C; Diez, F; Franchi, A; Gervasi, MG; Osycka-Salut, C; Perez-Martinez, S | 1 |
1 review(s) available for probenecid and adenosine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for probenecid and adenosine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Is cyclic AMP involved in excitatory amino acid-evoked adenosine release from rat cortical slices?
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Calcium; Chromatography, High Pressure Liquid; Colforsin; Cyclic AMP; Excitatory Amino Acids; Male; N-Methylaspartate; Parietal Lobe; Probenecid; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1994 |
Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture.
Topics: Adenine Nucleotides; Adenosine; Animals; Astrocytes; Cells, Cultured; Cerebral Cortex; Cyclic AMP; Extracellular Space; Isoproterenol; Neurons; Osmolar Concentration; Phosphodiesterase Inhibitors; Probenecid; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Reproducibility of Results | 1994 |
Metabolism of cAMP to adenosine in the renal vasculature.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Animals; Cells, Cultured; Cyclic AMP; Male; Muscle, Smooth, Vascular; Perfusion; Probenecid; Rats; Rats, Sprague-Dawley; Renal Veins | 1997 |
Involvement of P1 receptors in the effect of forskolin on cyclic AMP accumulation and export in PC12 cells.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Colforsin; Cyclic AMP; PC12 Cells; Probenecid; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Theophylline; Time Factors | 1999 |
Masking of forskolin-induced long-term potentiation by adenosine accumulation in area CA1 of the rat hippocampus.
Topics: 2-Amino-5-phosphonovalerate; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Animals; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Hippocampus; Long-Term Potentiation; Male; Nerve Fibers; Neurons; Probenecid; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Synapses; Thionucleotides; Xanthines | 1999 |
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines | 2003 |
THE EFFECT OF L-EPINEPHRINE AND OTHER AGENTS ON THE SYNTHESIS AND RELEASE OF ADENOSINE 3',5'-PHOSPHATE BY WHOLE PIGEON ERYTHROCYTES.
Topics: Adenine Nucleotides; Adenosine; Animals; Birds; Caffeine; Columbidae; Epinephrine; Erythrocytes; Isoproterenol; Magnesium; Norepinephrine; Pharmacology; Phosphates; Probenecid; Research; Sympatholytics | 1963 |
The pancreatohepatorenal cAMP-adenosine mechanism.
Topics: Adenosine; Adenosine Monophosphate; Animals; Cyclic AMP; Glucagon; Glucose; Inosine; Kidney; Liver; Male; Microdialysis; Pancreas; Probenecid; Rats | 2007 |
Cyclic AMP efflux, via MRPs and A1 adenosine receptors, is critical for bovine sperm capacitation.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine A1 Receptor Antagonists; Adenylyl Cyclase Inhibitors; Animals; Bicarbonates; Biological Transport; Cattle; Cyclic AMP; Humans; Male; Multidrug Resistance-Associated Proteins; Phosphodiesterase Inhibitors; Probenecid; Receptor, Adenosine A1; Sperm Capacitation; Sperm Motility; Spermatozoa; Xanthines | 2014 |